Search results for "Diabetes"
Be on alert for blood cancer precursors
Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
https://immattersacp.org/archives/2023/07/be-on-alert-for-blood-cancer-precursors.htm
1 Jul 2023
MKSAP Quiz: Decreased libido, fatigue
A 32-year-old man is evaluated for decreased libido and fatigue. His symptoms have increased over the last 6 months. Following a physical exam and visual exam, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2020/07/07/3.htm
7 Jul 2020
New drugs approved for type 2 diabetes and COPD
This regulatory update covers dapaglifozin (Farxiga) a sodium-glucose co-transporter 2 inhibitor, to treat diabetes, and umeclidinium and vilanterol inhalation (Anoro Ellipta) for maintenance of chronic obstructive pulmonary disease.
https://immattersacp.org/archives/2014/03/fda.htm
1 Mar 2014
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2022
Outpatient intensification of diuretics associated with increased mortality in heart failure
A retrospective cohort study of Danish patients who were diagnosed with heart failure from 2001 to 2016 highlighted the significance of need for intensified diuretics as an indicator of worsening heart failure, the authors said.
https://immattersacp.org/weekly/archives/2020/07/21/5.htm
21 Jul 2020
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Food insecurity threatens public health in the U.S., ACP says
A College position paper makes recommendations for strengthening the nation's food insecurity response, while new research finds that social programs for housing, food, and transportation may help reduce inpatient admissions and ED visits in adult Medicaid patients.
https://immattersacp.org/weekly/archives/2022/07/05/2.htm
5 Jul 2022
MKSAP quiz: Appropriate treatment for primary hyperaldosteronism
A 67-year-old man is evaluated during a follow-up visit for resistant hypertension. He was recently evaluated for primary hyperaldosteronism, and the screening plasma aldosterone concentration/plasma renin activity ratio was >20. A dedicated adrenal CT scan showed diffuse bilateral adrenal hyperplasia. After history and physical, cardiac and pulmonary exams, and discussion of patient preferences, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/07/19/3.htm
19 Jul 2022
Experts offer advice on oral drugs, insulin for diabetes
Any type 2 diabetic is eventually going to need oral medications, and some on oral medications may eventually progress to needing insulin. The regimens are complex and vary from patient to patient. Learn how to individually tailor such decisions.
https://immattersacp.org/archives/2011/06/diabetes.htm
1 Jun 2011
MKSAP Quiz: Routine follow-up appointment with schizophrenia
A 56-year-old man is evaluated during a routine follow-up appointment. He has schizophrenia treated with olanzapine. Currently, the patient experiences no hallucinations or delusions. He is otherwise healthy. Following a physical exam, what should also be monitored in this patient?
https://immattersacp.org/weekly/archives/2021/10/26/3.htm
26 Oct 2021